Quantbot Technologies LP Gossamer Bio, Inc. Transaction History

Quantbot Technologies LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$0.98 - $1.53 $34,146 - $53,309	-34,843 Reduced 44.93%	42,703 $51,000
Q1 2023 May 12, 2023	BUY	$0.96 - $2.92 $74,444 - $226,434	77,546 New	77,546 $97,000
Q3 2022 Nov 07, 2022	BUY	$7.21 - $14.88 $199,904 - $412,562	27,726 Added 606.03%	32,301 $386,000
Q2 2022 Aug 09, 2022	SELL	$5.97 - $9.97 $55,079 - $91,983	-9,226 Reduced 66.85%	4,575 $38,000
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $11,824 - $17,498	1,401 Added 11.3%	13,801 $119,000
Q4 2021 Feb 11, 2022	SELL	$10.12 - $14.07 $10,120 - $14,070	-1,000 Reduced 7.46%	12,400 $140,000
Q3 2021 Nov 09, 2021	BUY	$7.25 - $13.23 $97,150 - $177,282	13,400 New	13,400 $168,000
Q2 2021 Aug 12, 2021	SELL	$8.0 - $9.75 $8,000 - $9,750	-1,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$8.63 - $10.94 $8,630 - $10,940	1,000 New	1,000 $9,000
Q4 2020 Feb 12, 2021	SELL	$8.3 - $13.59 $6,640 - $10,872	-800 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $9,040 - $11,800	800 New	800 $9,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.